Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 1,060,087
- Estimated value
- $3,381,677
- Report date
- 30 Jun 2026
- Price
- $3.19
- Ownership
- Direct
Robert N. Fried - Chief Executive Officer, Director at Niagen Bioscience, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- NAGE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert N. Fried since 13 Sep 2025
Reported holdings for Robert N. Fried in Niagen Bioscience, Inc.
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 250,000
- Estimated value
- $797,500
- Report date
- 30 Jun 2026
- Price
- $3.19
- Ownership
- By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 250,000
- Estimated value
- $797,500
- Report date
- 30 Jun 2026
- Price
- $3.19
- Ownership
- By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 95,001
- Estimated value
- $303,053
- Report date
- 30 Jun 2026
- Price
- $3.19
- Ownership
- By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 12,746
- Estimated value
- $40,659
- Report date
- 30 Jun 2026
- Price
- $3.19
- Ownership
- Indirect
Form 4 holding
Chief Executive Officer, Director
ChromaDex Corp.
- Security class
- Performance Stock Unit
- Shares / value
- 1,518,600
- Estimated value
- Report date
- 25 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Employee Stock Options (right to buy)
- Shares / value
- 503,937
- Estimated value
- Report date
- 19 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Niagen Bioscience, Inc.
- Security class
- Stock Options (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 24 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert N. Fried in Niagen Bioscience, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.